UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

181 DOSE-DEPENDENT REDUCTIONS IN SERUM FERRITIN CORRELATE WITH CHANGES IN SERUM TRANSAMINASE LEVELS DURING LONG-TERM IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®, ICL670)

Journal of hepatology, 2008, Vol.48, p.S77-S77

2008

Volltextzugriff (PDF)

Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity

The Journal of biological chemistry, 1994-11, Vol.269 (45), p.28143-28151

1994

Volltextzugriff (PDF)

189 EFFECT OF IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®, ICL670) OR DEFEROXAMINE ON HEPATOCELLULAR INFLAMMATION AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONDEPENDENT ANEMIA

Journal of hepatology, 2008, Vol.48, p.S79-S80

2008

Volltextzugriff (PDF)

Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro

Molecular and Cellular Biology, 1989-12, Vol.9 (12), p.5718-5721

1989

Volltextzugriff (PDF)

P-113 The efficacy and tolerabilityof ICL670, a once-daily oral iron chelator, in patients with myelodysplastic syndrome (MDS) and iron overload

Leukemia research, 2005, Vol.29, p.S67-S67

2005

Volltextzugriff (PDF)

Phase IB Dose-Escalation Study of BEZ235 or BKM120 in Combination with Paclitaxel (PTX) in Patients With Advanced Solid Tumors

Annals of oncology, 2012-09, Vol.23, p.ix157-ix158

2012

Volltextzugriff (PDF)

Correlation between Dose-Dependent Reductions in Serum Transaminase (ALT) and Serum Ferritin Levels during Long-Term Chelation Therapy with Deferasirox (Exjade®, ICL670)

Blood, 2006-11, Vol.108 (11), p.3817-3817

2006

Volltextzugriff (PDF)

Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Is Effective in Reducing Iron Overload in Patients with Advanced Fibrosis and Cirrhosis

Blood, 2005-11, Vol.106 (11), p.2696-2696

2005

Volltextzugriff (PDF)

Comparative Pharmacokinetic/Pharmacodynamic Profiles in Japanese and Caucasian Patients with Transfusional Hemosiderosis Receiving Treatment with Deferasirox (Exjade®, ICL670)

Blood, 2006-11, Vol.108 (11), p.4845-4845

2006

Volltextzugriff (PDF)

Deferasirox (Exjade®, ICL670) Demonstrates Dose-Related Effects on Body Iron Levels Related to Transfusional Iron Intake in Transfusion-Dependent Anemia

Blood, 2005-11, Vol.106 (11), p.2694-2694

2005

Volltextzugriff (PDF)

Iron Chelation Efficiency of Deferasirox (Exjade®, ICL670) in Patients with Transfusional Hemosiderosis

Blood, 2005-11, Vol.106 (11), p.2690-2690

2005

Volltextzugriff (PDF)

Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Results in Reduced Hepatocellular Inflammation and Improved Liver Function in Patients with Transfusion-Dependent Anemia

Blood, 2005-11, Vol.106 (11), p.823-823

2005

Volltextzugriff (PDF)

Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis

Oncogene, 1996-08, Vol.13 (4), p.877-881

1996

Volltextzugriff (PDF)

Mode of action of the antitumor compound girodazole (RP 49532A, NSC 627434)

Biochemical pharmacology, 1992-04, Vol.43 (8), p.1717-1723

1992

Volltextzugriff (PDF)

Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein

The New biologist, 1992-05, Vol.4 (5), p.512

1992

Volltextzugriff (PDF)

Antitumor activity and mechanism of action of the marine compound girodazole

Investigational new drugs, 1991-08, Vol.9 (3), p.233-244

1991

Volltextzugriff (PDF)

All-Optical Bose-Einstein Condensates in Microgravity

Physical review letters, 2019-12, Vol.123 (24), p.240402-240402, Article 240402

2019

Volltextzugriff (PDF)

Definition of an Ets1 Protein Domain Required for Nuclear Localization in Cells and DNA-Binding Activity In Vitro

Molecular and cellular biology, 1989-12, Vol.9 (12), p.5718-5721

1989

Volltextzugriff (PDF)

Testing the universality of free fall using correlated 39K–87Rb atom interferometers

AVS quantum science, 2022-03, Vol.4 (1)

2022

Volltextzugriff (PDF)

Se baigner dans la Seine dans le cadre des Jeux olympiques de 2024 : quels sont les risques encourus par les athlètes ? Une évaluation des risques microbiologiques et chimiques

Archives des maladies professionnelles et de l'environnement, 2024-08, Vol.85 (4), p.102760, Article 102760

2024

Volltextzugriff (PDF)

Recent progress in high pressure metrology in Europe

EPJ Web of conferences, 2014, Vol.77, p.6-1-00006-11

2014

Volltextzugriff (PDF)

Physical Process Cruise 2018

The Nansen Legacy Report Series, 2020-07 (2)

2020

Volltextzugriff (PDF)

A Self-referenced and regulated sensing solution for PCM with OTS selector

2021 IFIP/IEEE 29th International Conference on Very Large Scale Integration (VLSI-SoC), 2021, p.1-6

2021

Volltextzugriff (PDF)

Final Report on Key Comparison CCM.P-K7 in the range 10 MPa to 100 MPa of hydraulic gauge pressure

Metrologia, 2005-01, Vol.42 (1A), p.07005-7005

2005

Volltextzugriff (PDF)

REFIMEVE Fiber Network for Time and Frequency Dissemination and Applications

2023 Joint Conference of the European Frequency and Time Forum and IEEE International Frequency Control Symposium (EFTF/IFCS), 2023, p.1-4

2023

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

181 DOSE-DEPENDENT REDUCTIONS IN SERUM FERRITIN CORRELATE WITH CHANGES IN SERUM TRANSAMINASE LEVELS DURING LONG-TERM IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®, ICL670)

Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity

189 EFFECT OF IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®, ICL670) OR DEFEROXAMINE ON HEPATOCELLULAR INFLAMMATION AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONDEPENDENT ANEMIA

Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro

P-113 The efficacy and tolerabilityof ICL670, a once-daily oral iron chelator, in patients with myelodysplastic syndrome (MDS) and iron overload

Phase IB Dose-Escalation Study of BEZ235 or BKM120 in Combination with Paclitaxel (PTX) in Patients With Advanced Solid Tumors

Correlation between Dose-Dependent Reductions in Serum Transaminase (ALT) and Serum Ferritin Levels during Long-Term Chelation Therapy with Deferasirox (Exjade®, ICL670)

Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Is Effective in Reducing Iron Overload in Patients with Advanced Fibrosis and Cirrhosis

Comparative Pharmacokinetic/Pharmacodynamic Profiles in Japanese and Caucasian Patients with Transfusional Hemosiderosis Receiving Treatment with Deferasirox (Exjade®, ICL670)

Deferasirox (Exjade®, ICL670) Demonstrates Dose-Related Effects on Body Iron Levels Related to Transfusional Iron Intake in Transfusion-Dependent Anemia

Iron Chelation Efficiency of Deferasirox (Exjade®, ICL670) in Patients with Transfusional Hemosiderosis

Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Results in Reduced Hepatocellular Inflammation and Improved Liver Function in Patients with Transfusion-Dependent Anemia

Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis

Mode of action of the antitumor compound girodazole (RP 49532A, NSC 627434)

Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein

Antitumor activity and mechanism of action of the marine compound girodazole

All-Optical Bose-Einstein Condensates in Microgravity

Definition of an Ets1 Protein Domain Required for Nuclear Localization in Cells and DNA-Binding Activity In Vitro

Testing the universality of free fall using correlated 39K–87Rb atom interferometers

Se baigner dans la Seine dans le cadre des Jeux olympiques de 2024 : quels sont les risques encourus par les athlètes ? Une évaluation des risques microbiologiques et chimiques

Recent progress in high pressure metrology in Europe

Physical Process Cruise 2018

A Self-referenced and regulated sensing solution for PCM with OTS selector

Final Report on Key Comparison CCM.P-K7 in the range 10 MPa to 100 MPa of hydraulic gauge pressure

REFIMEVE Fiber Network for Time and Frequency Dissemination and Applications

Suchergebnisse filtern